You are currently viewing Psyched Wellness Becomes Latest Psychedelics Company to Go Public (CSE: PSYC)

Psyched Wellness Becomes Latest Psychedelics Company to Go Public (CSE: PSYC)

Your Brief

Psyched Wellness becomes the latest psychedelic-related company to trade publicly.

The Company claims to be focused on the production and distribution of functional mushrooms, with a nod to the psychedelic community in the below press release.


Full Press Release…

Psyched Wellness Ltd. to Commence Trading on the CSE on October 22, 2020

Toronto, Ontario–(Newsfile Corp. – October 21, 2020) – Psyched Wellness Ltd. (CSE: PSYC) (OTC Pink: DCNPF) (formerly Duncan Park Holdings Corporation) (the ” Company ” or ” Psyched “) a life sciences company focused on the production and distribution of artisanal functional mushrooms, is pleased to announce that it has received approval for the listing of the Company’s common shares on the Canadian Securities Exchange (the ” CSE “). The common shares will commence trading under the trading symbol “PSYC” on October 22, 2020.

Jeff Stevens, Chief Executive Officer of the Company said, “I am excited to share this announcement as it represents a significant milestone for the Company and our shareholders. We appreciate the support from our investors and the psychedelic community and look forward to contributing to the awareness and acceptance of various psychedelic compounds for increased health and wellness. To this effect, we look forward to sharing the Psyched story and educating people on the many benefits of Amanita Muscaria, a legal psychedelic fungi.”

For further information, please contact:
Jeffrey Stevens
Chief Executive Officer
Psyched Wellness Ltd.
Tel: 647-400-8494

Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release.

About Psyched Wellness Ltd .:

Psyched Wellness Ltd. is a Canadian-based health supplements company dedicated to the distribution of mushroom-derived products and associated consumer packaged goods. The Company’s objective is to create premium mushroom-derived products that have the potential to become a leading North American brand in the emerging functional food category. The Company is in the process of developing a line of Amanita muscaria-derived water-based extracts, teas and capsules designed to help with three health objectives: promote stress relief, relaxation and assist with restful sleeping.

Cautionary Statement Regarding Forward-Looking Information and Statements

This press release contains ‘forward-looking information’ within the meaning of applicable Canadian securities legislation. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on Psyched Wellness Ltd. current belief or assumptions as to the outcome and timing of such future events. Forward-looking information is based on reasonable assumptions that have been made by Psyched at the date of the information and is subject to known and unknown risks, uncertainties, and other factors that may cause actual results or events to differ materially from those anticipated in the forward-looking information. Given these risks, uncertainties, and assumptions, you should not unduly rely on these forward-looking statements. The forward-looking information contained in this press release is made as of the date hereof, and Psyched is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. The foregoing statements expressly qualify any forward-looking information contained herein. Factors that could cause actual results to differ materially from those anticipated in these forward-looking statements are described under the caption “Risk Factors” in Psyched Wellness Ltd. management’s discussion and analysis for the six months ended May 31, 2020 and covering the subsequent period up to July 27, 2020 (“MD&A”), dated July 27, 2020, which is available on Psyched Wellness Ltd. profile.

This news release does not constitute an offer to sell or the solicitation of an offer to buy, and shall not constitute an offer, solicitation or sale in any state, province, territory or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state, province, territory or jurisdiction.

Leave a Reply